期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肝癌患者血浆RASSF1A异常甲基化检测的意义 被引量：6

Diagnostic value of detection of aberrantly methylated RASSF1A in plasma of patients with hepatocellular carcinoma
暂未订购
导出
摘要 目的采用甲基化特异性PCR法(MSP)检测41例原发性肝癌(HCC)患者血浆中游离Ras相关结构域家族蛋白1A(RASSF1A)异常高甲基化情况,探讨血浆RASSF1A检测在肝癌诊断中的意义.方法收集患者血浆,提取游离DNA,亚硫酸氢钠修饰并纯化,以甲基化特异性引物及非甲基化引物进行PCR.结果41例患者血浆中有17例RASSF1A呈现异常高甲基化(41.5%),对照血浆均为阴性.患者一般情况、临床病理资料等与血浆中RASSF1A异常高甲基化检测结果无关(P>0.05);在10例AFP阴性的HCC患者中,有7例结果为阳性.结论血浆RASSF1A甲基化检测对肝癌的早期诊断及筛选有重要意义,并有助于判断预后. AIM： To study the aberrant methylation status of Ras association domain family 1A （RASSF1A） in the plasma of patients with hepatocellular carcinoma （HCC） by methylationspecific PCR （MSP） , and to explore the value of circular tumorrelated DNA in diagnosis of HCC. METHODS： Free DNA was extracted from peripheral blood plasma of 41 HCC patients. After modified with sodium bisulfite and purified, the DNA was amplified using primers specific for methylated and unmethylated sequences of RASSF1A. RESULTS： Aberrant RASSF1A methylation was found in 41.5% （ 17 of 41 ） of plasma DNA in HCC patients. No methylated RASSF1A was detected in 10 cases of control plasma samples. Clinical data including age, sex, clinical stages, levels of AFP, hepatitis status, number of tumor, invasion, metastasis and cirrhosis showed no correlation with aberrant methylation of RASSF1A （ P 〉 0. 05 ）. Aberrantly methylated RASSF1A was also detected in 7 of 10 plasma samples of AFP negative cases. CONCLUSION： Detection of aberrant methylation of RASSF1A in blood is feasible to early detect and screen HCC, and is useful to estimate the prognosis.
作者 赵强子 祁志芳 魏万礼 李开宗 窦科峰
机构地区 第四军医大学西京医院肝胆外科 解放军第十医院
出处 《第四军医大学学报》 北大核心 2006年第17期1577-1579,共3页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30371399)
关键词 肝肿瘤 RASSF1A基因 甲基化 血浆 liver neoplasms Ras association domain family 1A methylation plasma
分类号 R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献9

  • 1Pfeifer GP,Yoon JH,Liu L,et al.Methylation of the RASSF1A gene in human cancers[J].Biol Chem,2002,383(6):907-914.
  • 2安锦霞,杨永秀,黎卫平.RASSF1A基因在宫颈癌组织中的表达及意义[J].第四军医大学学报,2005,26(7):657-660. 被引量：7
  • 3Fujiwara K,Fujimoto N,Tabata M,et al.Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer[J].Clin Cancer Res,2005,11(3):1219-1225.
  • 4Ramirez JL,Taron M,Balana C,et al.Serum DNA as a tool for cancer patient management[J].Rocz Akad Med Bialymst,2003,48:34-41.
  • 5Ibanez dC,I,Battagli C,Esteller M,et al.Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum,plasma,and peritoneal fluid from ovarian cancer patients[J].Cancer Res,2004,64(18):6476-6481.
  • 6Maruyama R,Toyooka S,Toyooka KO,et al.Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features[J].Clin Cancer Res,2002,8(2):514-519.
  • 7Hoque MO,Begum S,Topaloglu O,et al.Quantitative detection of promoter hypermethylation of multiple genes in the tumor,urine,and serum DNA of patients with renal cancer[J].Cancer Res,2004,64(15):5511-5517.
  • 8Kang GH,Lee S,Lee HJ,Hwang KS.Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia[J].J Pathol,2004,202(2):233-240.
  • 9Muller HM,Widschwendter A,Fiegl H,et al.DNA methylation in serum of breast cancer patients:An independent prognostic marker[J].Cancer Res,2003,63(22):7641-7645.

二级参考文献12

  • 1Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumors [J]. Oncogene, 2001; 20 ( 12 ): 1509 - 1518.
  • 2Byun DS, Lee MG, Chae KS, et al. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma [J]. Cancer Res, 2001; 61(19): 7034-7038.
  • 3Maruyama R, Toyooka S, Kiyomi O, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features[J]. Clin Cancer Res, 2002; 8(2) :514 -519.
  • 4Hogg RP, Honorio S, Martinez A, et al. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumor suppressor gene from region 3p21.3 in head and neck squamous cell carcinomas[J]. Eur J Cancer, 2002; 38(12): 1585-1592.
  • 5Yu MY, Tong JHM, Chan PKS, et al. Hypermethylation of the tumor suppressor gene RASSF1A and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers[J]. Int J Cancer, 2003;105(2) :204 -209.
  • 6Kuzmin I, Liu L, Dammann R, et al. Inactivation of Ras association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection [J]. Cancer Res, 2003; 63 ( 8 ):1888 - 1893.
  • 7Cohen Y, Singer G, Lavie O, et al. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix [J]. Clin Cancer Res, 2003; 9(8): 2981 -2984.
  • 8Dammann R,Li C,Yoon JH,et al.Epigeneticinactivation of a ras association domain family protein from the lung tumor suppressor locus 3p21.3[J].Nat Genet,2000;25(3):315-319.
  • 9Zhu XX, Deng D, Kuick R, et al. Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome [J]. Proc Natl Acal Sci USA, 1999; 96(14) :8058 -8063.
  • 10Ip SM, Wong LC, Xu CM, et al. Detection of human papillomavirus DNA in malignant lesions from Chinese women with carcinomas of upper genital tract [J]. Gynecol Oncol, 2002; 87 ( 1 ): 104 - 111.

共引文献6

同被引文献70

引证文献6

二级引证文献24

第四军医大学学报
2006年 第17期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部